174 related articles for article (PubMed ID: 24864229)
21. Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine.
Zhang YX; Liu XM; Wang J; Li J; Liu Y; Zhang H; Yu XW; Wei N
Cancer Biol Ther; 2015; 16(6):965-75. PubMed ID: 25893985
[TBL] [Abstract][Full Text] [Related]
22. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells.
Yang L; Xie S; Jamaluddin MS; Altuwaijri S; Ni J; Kim E; Chen YT; Hu YC; Wang L; Chuang KH; Wu CT; Chang C
J Biol Chem; 2005 Sep; 280(39):33558-65. PubMed ID: 16061480
[TBL] [Abstract][Full Text] [Related]
23. An aqueous extract of Fagonia cretica induces DNA damage, cell cycle arrest and apoptosis in breast cancer cells via FOXO3a and p53 expression.
Lam M; Carmichael AR; Griffiths HR
PLoS One; 2012; 7(6):e40152. PubMed ID: 22761954
[TBL] [Abstract][Full Text] [Related]
24. p53-dependent inhibition of FKHRL1 in response to DNA damage through protein kinase SGK1.
You H; Jang Y; You-Ten AI; Okada H; Liepa J; Wakeham A; Zaugg K; Mak TW
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14057-62. PubMed ID: 15383658
[TBL] [Abstract][Full Text] [Related]
25. Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo.
Zhou R; Lu Z; Liu K; Guo J; Liu J; Zhou Y; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2015; 14(9):860-71. PubMed ID: 25431082
[TBL] [Abstract][Full Text] [Related]
26. FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in Prostate Cancer.
Imada K; Shiota M; Kuroiwa K; Sugimoto M; Abe T; Kohashi K; Yokomizo A; Eto M; Naito S; Oda Y
Prostate; 2017 Feb; 77(2):145-153. PubMed ID: 27699813
[TBL] [Abstract][Full Text] [Related]
27. RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells.
Xu Y; Fang F; Sun Y; St Clair DK; St Clair WH
Mol Cancer Ther; 2010 Apr; 9(4):803-12. PubMed ID: 20371728
[TBL] [Abstract][Full Text] [Related]
28. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells.
Li Y; Wang Z; Kong D; Murthy S; Dou QP; Sheng S; Reddy GP; Sarkar FH
J Biol Chem; 2007 Jul; 282(29):21542-50. PubMed ID: 17522055
[TBL] [Abstract][Full Text] [Related]
29. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
[TBL] [Abstract][Full Text] [Related]
30. Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression.
Li C; Sun H; Wei W; Liu Q; Wang Y; Zhang Y; Lian F; Liu F; Li C; Ying K; Huo H; Qi Z; Li B
Cell Oncol (Dordr); 2020 Dec; 43(6):1099-1116. PubMed ID: 32710433
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
32. Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic.
Sherk AB; Frigo DE; Schnackenberg CG; Bray JD; Laping NJ; Trizna W; Hammond M; Patterson JR; Thompson SK; Kazmin D; Norris JD; McDonnell DP
Cancer Res; 2008 Sep; 68(18):7475-83. PubMed ID: 18794135
[TBL] [Abstract][Full Text] [Related]
33. Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.
Szmulewitz RZ; Chung E; Al-Ahmadie H; Daniel S; Kocherginsky M; Razmaria A; Zagaja GP; Brendler CB; Stadler WM; Conzen SD
Prostate; 2012 Feb; 72(2):157-64. PubMed ID: 21563193
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.
Chiang KC; Tsui KH; Chung LC; Yeh CN; Feng TH; Chen WT; Chang PL; Chiang HY; Juang HH
Sci Rep; 2014 Jul; 4():5511. PubMed ID: 24981574
[TBL] [Abstract][Full Text] [Related]
35. FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells.
Liu H; Yin J; Wang C; Gu Y; Deng M; He Z
Anticancer Drugs; 2014 Sep; 25(8):898-907. PubMed ID: 24814195
[TBL] [Abstract][Full Text] [Related]
36. Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin.
Wu J; Tang Q; Zhao S; Zheng F; Wu Y; Tang G; Hahn SS
Int J Oncol; 2014 Jul; 45(1):95-103. PubMed ID: 24806432
[TBL] [Abstract][Full Text] [Related]
37. Deregulation of FoxO3a accelerates prostate cancer progression in TRAMP mice.
Shukla S; Bhaskaran N; Maclennan GT; Gupta S
Prostate; 2013 Oct; 73(14):1507-17. PubMed ID: 23765843
[TBL] [Abstract][Full Text] [Related]
38. Deregulation of FOXO3A during prostate cancer progression.
Shukla S; Shukla M; Maclennan GT; Fu P; Gupta S
Int J Oncol; 2009 Jun; 34(6):1613-20. PubMed ID: 19424579
[TBL] [Abstract][Full Text] [Related]
39. SGK1 mediates the hypotonic protective effect against H
Chen BY; Huang CC; Lv XF; Zheng HQ; Zhang YJ; Sun L; Wang GL; Ma MM; Guan YY
Acta Pharmacol Sin; 2020 Aug; 41(8):1073-1084. PubMed ID: 32139897
[TBL] [Abstract][Full Text] [Related]
40. Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
Fagerli UM; Ullrich K; Stühmer T; Holien T; Köchert K; Holt RU; Bruland O; Chatterjee M; Nogai H; Lenz G; Shaughnessy JD; Mathas S; Sundan A; Bargou RC; Dörken B; Børset M; Janz M
Oncogene; 2011 Jul; 30(28):3198-206. PubMed ID: 21478911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
